Elevance Health Inc. (ELV) Stock Overview
Explore Elevance Health Inc.’s financial performance, market position, analyst ratings, and future outlook.
Elevance Health Inc. (ELV)
Key Financials
Key Financials
Market Cap
85.4B
P/E Ratio
17.40
EPS (TTM)
$29.39
ROE
0.11%
ELV Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Elevance Health Inc. (ELV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 48.04, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $371.62.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 17.40 and a market capitalization of 85.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.